{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:22:59Z","timestamp":1760908979105},"reference-count":35,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","nutritionjrnl.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.nut.2016.01.015","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T16:47:00Z","timestamp":1454086020000},"page":"855-862","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice hearts at later stages of dystrophy"],"prefix":"10.1016","volume":"32","author":[{"given":"Adriana","family":"Fogagnolo Mauricio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliano Alves","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Santo Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Julia","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2016.01.015_bib1","series-title":"Myology","first-page":"1133","article-title":"Distrophinopathies","author":"Engel","year":"1994"},{"key":"10.1016\/j.nut.2016.01.015_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrcardio.2013.213","article-title":"Treatment of dystrophin cardiomyopathies","volume":"11","author":"Finsterer","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.nut.2016.01.015_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbadis.2006.05.010","article-title":"Dystrophin, its interactions with other proteins, and implications for muscular dystrophy","volume":"1772","author":"Ervasti","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nut.2016.01.015_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00441-005-1102-z","article-title":"Silencing TNF activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts: an in\u00a0vivo bioassay to assess the efficacy of anti-cytokine drugs in mice","volume":"320","author":"Grounds","year":"2005","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.nut.2016.01.015_bib5","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1093\/hmg\/ddp191","article-title":"Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletam muscle regeneration in muscular dystrophy","volume":"18","author":"Li","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nut.2016.01.015_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy","volume":"8","author":"McGreevy","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.nut.2016.01.015_bib7","first-page":"9","article-title":"Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy","volume":"31","author":"Angelini","year":"2012","journal-title":"Acta Myol"},{"key":"10.1016\/j.nut.2016.01.015_bib8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.clnu.2012.11.013","article-title":"Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice","volume":"32","author":"Fogagnolo Mauricio","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2016.01.015_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2013.09.007","article-title":"EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype","volume":"264","author":"Carvalho","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nut.2016.01.015_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2010.10.032","article-title":"Eicosapentaenoic acid decreases TNF-alpha and protects dystrophic muscles of mdx mice from degeneration","volume":"232","author":"Machado","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nut.2016.01.015_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13058-015-0571-6","article-title":"Omega-3 fatty acids for breast cancer prevention and survivorship","volume":"17","author":"Fabian","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.nut.2016.01.015_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10557-012-6397-x","article-title":"The use of \u03a9-3 poly-unsaturated fatty acids in heart failure: a preferential role in patients with diabetes","volume":"26","author":"Kazemian","year":"2012","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.nut.2016.01.015_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/352536a0","article-title":"The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy","volume":"352","author":"Stedman","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.nut.2016.01.015_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-7-24","article-title":"The omega-3 fatty acid, eicosapentaenoic acid (EPA), prevents the damaging effects of tumor necrosis factor (TNF)-alpha during murine skeletal muscle cell differentiation","volume":"7","author":"Magee","year":"2008","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.nut.2016.01.015_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/mus.23858","article-title":"Suramin attenuates dystrophin-deficient cardiomyopathy in the mdx mice model of Duchenne muscular dystrophy","volume":"48","author":"Moreira","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nut.2016.01.015_bib16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?","volume":"75","author":"Calder","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.nut.2016.01.015_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01270572","article-title":"Eicosapentaenoic and docosahexaenoic acids in cultured rat ventricular myocytes and hypoxia-induced alterations of phospholipase-A activity","volume":"116","author":"Grynberg","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.nut.2016.01.015_bib18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1006\/jmcc.1996.0101","article-title":"Eicosapentaenoic acid incorporation in membrane phospholipids modulates receptor-mediated phospholipase C and membrane fluidity in rat ventricular myocytes in culture","volume":"28","author":"De Jonge","year":"1996","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nut.2016.01.015_bib19","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1006\/jmcc.1995.0238","article-title":"Effect of docosahexaenoic acid and eicosapentaenoic acid in the phospholipids of rat heart muscle cells on adrenoceptor responsiveness and mechanism","volume":"27","author":"Grynberg","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nut.2016.01.015_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbalip.2008.07.009","article-title":"Protective effect of eicosapentaenoic acid on palmitate-induced apoptosis in neonatal cardiomyocytes","volume":"1781","author":"Leroy","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nut.2016.01.015_bib21","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1006\/jmcc.1999.1018","article-title":"Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne Muscular Dystrophy","volume":"31","author":"Bia","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nut.2016.01.015_bib22","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbamcr.2012.08.023","article-title":"Fibroblasts in post-infarction inflammation and cardiac repair","volume":"1833","author":"Chen","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nut.2016.01.015_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nmd.2011.05.011","article-title":"Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)","volume":"21","author":"Nadarajah","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nut.2016.01.015_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bcp.2007.07.004","article-title":"Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease","volume":"75","author":"Raffetto","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nut.2016.01.015_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0008-6363(00)00003-1","article-title":"Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling","volume":"46","author":"Li","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.nut.2016.01.015_bib26","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1093\/hmg\/ddr362","article-title":"Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice","volume":"20","author":"Dahiya","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nut.2016.01.015_bib27","first-page":"723","article-title":"Osteopontin-stimulated expression of matrix metalloprotreinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy","volume":"87","author":"Dahiya","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.nut.2016.01.015_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.nut.2016.01.015_bib29","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/hmg\/ddr062","article-title":"Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers","volume":"20","author":"Miyazaki","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nut.2016.01.015_bib30","doi-asserted-by":"crossref","first-page":"E96286","DOI":"10.1371\/journal.pone.0096286","article-title":"The omega-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2016.01.015_bib31","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1093\/hmg\/ddu113","article-title":"Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10","volume":"23","author":"Nitahara-Kasahara","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nut.2016.01.015_bib32","doi-asserted-by":"crossref","first-page":"16036","DOI":"10.1074\/jbc.M700641200","article-title":"Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity","volume":"282","author":"Michaluk","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nut.2016.01.015_bib33","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.2903\/j.efsa.2012.2815","article-title":"Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid","volume":"10","author":"European Food Safety Authority","year":"2012","journal-title":"EFSA J"},{"key":"10.1016\/j.nut.2016.01.015_bib34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.nut.2016.01.015_bib35","first-page":"5022","article-title":"Inhibition of weight loss by omega-3 fatty acids in an experimental cachexia model","volume":"50","author":"Tisdale","year":"1990","journal-title":"Cancer Res"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900716000484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900716000484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T03:57:20Z","timestamp":1567569440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900716000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":35,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0899900716000484"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2016.01.015","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice hearts at later stages of dystrophy","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2016.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}